A percentage of ERα(−) breast cancer cells are composed of breast cancer stem cells, the most aggressive type of breast cancer where treatment requires either inhibition of Notch signaling [86] or treatment with the telomerase inhibitor Imetelstat [87]. The gene discussed is ESR1; the disease is breast carcinoma.